Votes & Verdicts cover art

All Episodes

Votes & Verdicts — 164 episodes

#
Title
1

Disney, Meta, Biofuel, IRS Shrinkage, Crypto

2

Crypto Law, NEC Trial, NIL Tax, Trump v. Fed

3

Crypto Bill, TV Owner Caps, Movie & AI Taxes

4

Paramount-WBD, Meta Trial, J&J Talc Pact

5

The End of Corporate Tax Inversions?

6

Lindsey Graham; Apple vs. OpenAI; Kenvue Blow

7

$1.4 Trillion Meta Suit, SpaceX, Data Centers

8

Policy & Litigation 2H Catalysts for Investors

9

Trump’s Cuba Plan and Business Implications

10

Bayer Roundup Suit’s SCOTUS Chances, Risks

11

Marijuana Rescheduling in Washington

12

Bayer Appeal of Roundup Suits at Supreme Court

13

Social Media Addicts, Seed Antitrust, AI Tax

14

Joyce Adetutu on Tariff Risks, Refunds

15

Can Trump Fix the Housing Affordability Pinch?

16

Why Mortgage Rates Are Stuck Above 6%

17

Proposed Ban on Institutional Home Ownership

18

Iran, Musk v. OpenAI, Live Nation, Visa, Pot

19

Treyz on Trump, Iran, Fed, Midterms, Tariffs

20

Trump’s Influence on Energy, Gasoline Prices

21

Ret. Col. Wayne Sanders on the Iran War

22

Betting on Prediction Markets — Path Ahead

23

Cato’s Skorup on Risks to Broadcast Licenses

24

Bank Rules, Anthropic, Sable, DOJ v. Powell

25

Sayyed on the State of Antitrust Enforcement

26

Bayer, Abbott, J&J Billion-Dollar Tort Risk

27

SCOTUS Tariff-Ruling Aftermath With Ted Murphy

28

Joyce Adetutu on SCOTUS IEEPA Tariff Ruling

29

Live Nation Antitrust, Kalshi, Nexstar-Tegna

30

Coinbase CLO Grewal on Crypto, Event Contracts

31

Ted Murphy on SCOTUS IEEPA Tariff Ruling

32

Orsted, Equinor, Peers in Offshore Headwinds

33

Credit Card Caps, FCC Fines, Powell Probe

34

NJ AG Platkin on AI, CFPB, Kalshi, Trump

35

Legal, Policy Catalysts for Investors 2026

36

Netflix/Paramount Antitrust, AI EO, Farm Aid

37

Warner Bros. Bids, Zillow, Bayer in SCOTUS

38

Meta Win, Trump’s AI Order, Epstein/JPMorgan

39

ACA Future, CFPB Funds, Visa/Mastercard Pact

40

Tariffs in SCOTUS; Pfizer v. Novo, Metsera

41

Trump in Asia, SNAP, H-1Bs, Apple Antitrust

42

IPOs, Trump v. NYT, FTC v. PBMs, BNP Paribas

43

Shutdown, Crypto, Fannie-Freddie, Musk’s Pay

44

Shutdown, H-1B Visas, Google, Abbott/Reckitt

45

Zillow Antitrust, TikTok, Tariffs, Shutdown

46

H-1B Fees, Anthropic, Shutdown Odds, Kenvue

47

Shutdown, Kimmel, Trump/NYT, FTC/LiveNation

48

Tariff Regulatory Risk? Ask a Trade Lawyer

49

Google Ruling, Tariffs/SCOTUS, Cook v. Trump

50

Cook v. Trump, Nexstar/Tegna, Govt. Shutdown

51

BI’s Larry Tabb on SEC’s Project Crypto

52

Trump on Fannie-Freddie, 401(k)s and Powell

53

Trump M&A, PBMs, Tariffs, FCC Broadcast Regs

54

Tariffs Legality, DC Shutdown, Dick’s M&A

55

Robinhood’s Gallagher on Tokenization, Crypto

56

Legality of Trump’s Tariffs With Professor Yoo

57

Bank Deregulation, Tariff Rulings Among 2H Catalysts

58

Tax Bill’s Impact on Solar, Health Care, AI

59

AI Copyright Rulings, Trump Antitrust, PBMs

60

‘L Day’ Tariff Legality, With Stanford’s Sykes

61

GENIUS Act, Texas v. BlackRock, DOJ v. Visa

62

Wells Fargo, Fed, DOJ v. Google, TikTok Ban

63

Tariff Rulings, Fannie-Freddie, FTC v. Pepsi

64

Tax Bill, Spectrum Auctions, Fannie-Freddie

65

Berman on Antitrust: View from Plaintiff Bar

66

IRA, Drug Pricing, Tech Antitrust, EchoStar: Votes and Verdicts

67

Tariff Suits, Broadcast Caps, Crypto Bills

68

Trump’s First 100 Days, Trade, Taxes and More

69

Tariff Suits, Tech Antitrust and Tax Bill

70

Meta Trial, Google Hearing, House Tax Vote

71

Trump’s Liberation Day: A Trade Lawyer’s Take: Votes & Verdicts

72

Are Trump’s Tariffs Legal? TikTok Ban Update

73

Trump SEC, Tariffs, FTC Firings, FCC Subsidy

74

Broadcasters Take Shot at FCC Media Limits

75

OpenAI, Meta Fair Use Bids Risky in Copyright Drama

76

Abbott, Apple, Citi, Nexstar, Musk, OpenAI

77

Ex-FBI Chief of Staff on Risks to Business

78

Arizona AG Mayes on Antitrust, PFAS and More

79

PFAS Could Make a Comeback Under Trump EPA

80

Washington Predictions — Tariffs, Tax, Trump

81

O’Rielly on the FCC’s Regulation Under Trump

82

TikTok Countdown After Supreme Court Showdown

83

Trump, TikTok, US Steel Among 2025 Catalysts

84

Abbott-Reckitt Multibillion-Dollar NEC Suits

85

Arm, Bayer, Google, Kroger, Novo, TikTok

86

Is the TMT Playbook About to Be Rewritten Under Trump?

87

Antitrust Under Trump – Post-Election View

88

Trump’s Win and Its Industry Impacts

89

Harris, Trump and Election Effects on Energy

90

Harris, Trump Election Impact on Antitrust

91

Harris, Trump Election Impact on Consumer

92

Harris, Trump Election Impact on Industrials

93

Harris, Trump Election Effect on Health-Care

94

Nixon Peabody Trust Company's Kern on Elections, Global Markets

95

Tax Implications of the 2024 US Election

96

BI Analysts Discuss US Election Impact on TMT

97

BI Strategists on the 2024 US Elections and Their Market Impact

98

Harris, Trump Election Effects on Financials

99

TikTok-Ban Risk Soars After Key Court Hearing

100

Bayer, Abbott Billion-Dollar Mass-Tort Risk

101

Anthony Scaramucci on Trump v. Harris

102

Coinbase, Google, TikTok and Other Catalysts

103

Medicare’s First Negotiated Price List Is Here

104

Forever Chemicals, the Forever Litigation?

105

Alphabet, Amazon, Apple and Meta Antitrust Showdown Status

106

Artificial Intelligence’s Antitrust Concerns

107

US Elections, GSK, Kroger and More Catalysts: Votes and Verdicts

108

Robinhood's Gallagher, BI's Tabb on Gensler's SEC

109

Joe Grogan’s Outlook for Health-Care Policy

110

Chevron Doctrine’s Demise and Industry Risk

111

US Elections, Google, Basel III Are 2H Keys

112

Lyft, Uber and the California Prop. 22 Brief

113

Kraninger on Bank Regulations, CFPB, Crypto

114

Net Neutrality Gets Another Day in Court

115

Calabria on Fannie, Freddie Conservatorships

116

Catalysts for Apple, Alphabet, GSK, and Visa

117

Todd Phillips on Basel III, Chevron, Crypto

118

Durbin on Credit Cards, Airline Programs

119

Medicare’s Hospital-at-Home and Other Reforms

120

Is TikTok on the Countdown to a Shutdown?

121

Google, LiveNation, Uber and Other Catalysts

122

Kelleher on FinReg, ‘Kangaroo’ Courts

123

Pharma and Biotech Drug Pricing Policy Outlook

124

Antitrust Enforcers’ New Merger Guidelines

125

Eugene Scalia on Beating Regulators in Court

126

Market and Reimbursement Outlook for Cell and Gene Therapies

127

3M, Synopsys, Capital One & Other Catalysts

128

Can Legal State Pot Put US Law Up in Smoke?

129

Biden’s Lab-Developed Test Proposal

130

Biden’s Drug-Pricing Expansion Plan, Part 2

131

Apple, Bayer, Moderna and Other Catalysts

132

Apple’s Antitrust App-Store Battle With Epic

133

Washington’s Crowded Outlook for 2024

134

Biden’s Drug Pricing March-in Proposal

135

Meta’s Biggest Legal, Regulatory Questions

136

Antitrust Changes Could Hinder M&A

137

Apple, Disney, Novo Nordisk, Other Catalysts

138

J&J, 3M's Chap 11 Play in Talc, Earplug Mass Torts

139

Berkshire, Google, Pega & Other Catalysts

140

Consumer Finance Impact of a CFPB Run Amok

141

Will IRA Drug Pricing Raise Employer Costs?

142

JJCI, Bayer, GSK, Mass Tort Litigation Risks

143

Bausch, GBTC, Merck, Meta & Other Catalysts

144

AI’s Biggest Legal and Regulatory Questions

145

FTC BioPharma M&A Approach Clashes With Sector

146

Likelihood Medicare Will Cover Obesity Drugs

147

3M, Drug Pricing, Google and Other Catalysts

148

Can Anyone Defeat Trump? Insights on the Forthcoming GOP Debates

149

3M, Google, Bank Rules, Other 2H Catalysts

150

Craig Burton on Inflation Reduction Act

151

Why PFAS Legal Risks Persist for 3M, Peers

152

Why a TikTok Ban Faces a Major Legal Hurdle

153

Catalysts to Watch – AI Laws, PFAS Trial

154

Adamantine’s Bays on Sustainable Investing

155

Margaux Hall on Drug Pricing Negotiation

156

Bill Hoagland on Debt-Ceiling Negotiations

157

Daniel Horwitz on Trump Indictment Strengths

158

Gottlieb on the Future of Crypto Policy, Law

159

The PFAS Problem, Regulatory and Other Issues

160

Crisis of Confidence, Regional Banks’ Future

161

The FTC’s Evolving Approach to Assessing M&A

162

The Biggest Tech-Regulation Questions

163

Energy's DC Opportunity, Risk with Schneider

164

Mulvaney on Crypto, the CFPB, and More